MedTrace Logo

Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean Delivery

NCT03328533 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2018-07-17

No results posted yet for this study

Summary

Comparison will be conducted between continuous variable infusions of Phenylephrine with starting dose of 0.75 mcg/Kg/min and Norepinephrine Bitartrate with starting dose of 0.1 mcg/Kg/min (with norepinephrine base of 0.05 mcg/Kg/min) for prophylaxis against Post-spinal hypotension during cesarean delivery

Conditions

  • Cesarean Section Complications
  • Spinal Anesthesia

Interventions

DRUG

Phenylephrine

Phenylephrine variable infusion with a starting rate of 0.75 mcg/Kg/min.

DRUG

Norepinephrine

Norepinephrine bitartrate variable infusion with a starting rate of 0.1 mcg/Kg/min (equivalent to norepinephrine base of 0.05 mcg/Kg/min).

DRUG

Bupivacaine

Bupivacaine will be injected in the subarachnoid space with a dose of 10 mg.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed M Mukhtar, Professor · Head of research committee section in anesthesia department

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-10
Primary Completion
2018-05-01
Completion
2018-05-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328533 on ClinicalTrials.gov